Modi's wife Jashodaben denied information under RTI

New Delhi, Mar 7: The Supreme Court on Friday stayed the bail granted by Karnataka High Court to 21 Popular Front of India (PFI) members accused in connection with violence that erupted during the protests against the Citizenship Amendment Act (CAA) in Karnataka's Mangaluru in December 2019.

On February 17, the High Court had granted bail to the accused on the bail petition filed by Mohammed Ashik.

A bench consisting Chief Justice S A Bobde issued notice to the accused on Friday after taking cognisance of the plea filed by Karnataka government against the bail granted by the High Court.

Appearing for the state government, Solicitor General Tushar Mehta criticised the High Court's order stating that at least 56 policemen sustained injuries during the violent protests.

Two persons identified as Jaleel (43) of Kudroli and Nousheen (49) of Bengre had died at a private hospital following the bullet injuries they sustained in an alleged police firing during a protest against CAA 2019.

Mangaluru, May 6: The Karnataka NRI Forum - UAE has collected the details of those seeking to return to Karnataka amidst coronavirus lockdown.

Of these, 121 of these expats are pregnant women, 27 are senior citizens, 157 are in urgent medical need, 522 are unemployed, 377 are in the UAE on visit visa, 109 are in the UAE on expired residency visa, 30 are students and 566 others.

On Tuesday, May 5, the Government of India released a list of flight schedules for the repatriation of Indians who are stranded abroad. "...sadly we do not see any flights going from UAE to Karnataka," the KNRI said in a letter to Union Minister of Chemicals and Fertilizers D V Sadananda Gowda, who is also a Kannadiga.

"We, Dubai Anivasi Kannadigaru and KNRI have collected the information of those who are in dire condition and would like to travel immediately. We would like to bring to your attention that in this list there are pregnant women and senior citizens who are in critical conditions and are waiting to travel," the KNRI wrote, urging the Union Minister to start at least one flight to Mangaluru as the majority are from this coastal city and not from Bengaluru.

Additionally, in order to help these struggling Kannadigas, the KNRI has notified the Government of India and Government of Karnataka several times through letters and conference calls, along with the Kannadiga's helpline, UAE.

With the help of likeminded businessmen and professionals, the KNRI Forum and Dubai Anivasi Kannadigaru have opened a helpline called "Kannadigas Helpline" through which they have received around 2,500 requests for food, medical, legal and other assistance.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.